Skip to content

Citrus Extract, Sleep and Mental Wellbeing

The Effect of Citrus Extract on Sleep and Mental Wellbeing

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06239168
Enrollment
40
Registered
2024-02-02
Start date
2023-11-08
Completion date
2024-12-31
Last updated
2024-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sleep Disturbance

Brief summary

This is a randomized, double-blind, placebo-controlled, cross-over trial investigating the effects of daily administration of citrus extract on sleep and mental wellbeing.

Detailed description

Based on epidemiological data, a substantial number of people report to have sleeping problems. This is of major concern, as poor sleep quality has been associated with impaired mental and physical health. Several pre-clinical studies have shown promising results, but evidence from human studies is still limited. Therefore, the aim of the present study is to investigate the effect of a citrus extract on sleep and mental wellbeing in healthy subjects with (minor) sleep disturbance.

Interventions

DIETARY_SUPPLEMENTCitrus extract

As described in experimental arm

DIETARY_SUPPLEMENTMaltodextrin

As described in comparator arm

Sponsors

BioActor
CollaboratorINDUSTRY
Maastricht University Medical Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
40 Years to 70 Years
Healthy volunteers
Yes

Inclusion criteria

* Healthy individuals with (minor) sleep disturbance * Age 40-70 years * BMI 18.5 - 30 kg/m2 * Willingness to give up being a blood donor from 4 weeks before the start of the study, during the study and for 4 weeks after completion of the study

Exclusion criteria

* Excessive caffeine use * Major psychiatric/mental health disorders . * Chronic sleep disorders * Severe sleep disturbance for more than 1 year * Other clear causes for poor sleep quality or mental wellbeing * Use of medication or supplements that can affect outcomes * Nonpharmacological treatment for sleep disorders * Flight from a time-zone with \>3 h difference ≤1 week before an intervention period * Administration of investigational drugs or participation in any scientific intervention study which may interfere with this study * Use of pre-, pro- or synbiotics within 1 month prior to the start of the study * Reported weight loss or weight gain of \>3 kg in the month prior to pre-study screening * Smoking * Abuse of products * Known allergy to citruses * Known pregnancy or lactation

Design outcomes

Primary

MeasureTime frameDescription
Changes in sleep quality scores between the intervention and placebo group8 weeks of interventionMeasured by a sleep quality questionnaire (PSQI)
Changes in sleep quality between the intervention and placebo group8 weeks of interventionMeasured using actigraphy

Secondary

MeasureTime frameDescription
Changes in mental wellbeing between the intervention and placebo group8 weeks of interventionMeasured by mental wellbeing questionnaires

Countries

Netherlands

Contacts

Primary ContactYala Stevens, PhD
yala.stevens@maastrichtuniversity.nl+31437114555

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026